August 25, 2014 — New data revealing the reduction in cardiovascular (CV) deaths with Novartis' LCZ696 in patients with ...
September 27, 2011 – Health 2.0 announced the launch of the Novartis CardioEngagement Challenge, asking multi ...
October 15, 2010 – The U.S. Food and Drug Administration (FDA) has approved an abbreviated new drug application (ANDA) ...
January 11, 2010 – A hypertension drug using a combination of telmisartan/amlodipine, which requires less-frequent ...
September 18, 2009 – The FDA has approved Valturna (aliskiren and valsartan) tablets, the first and only medicine to ...
July 22, 2009 – The FDA this week approved Tekturna HCT (aliskiren and hydrochlorothiazide) tablets as initial therapy ...
June 21, 2007 - Exforge, a single-tablet combination of two of the most prescribed high blood pressure medicines, has ...